DDIS-35. RelA-ACTIVITY IS ESSENTIAL FOR CANNABIDIOL-MEDIATED CYTOTOXICITY IN AN IDENTIFIED SUBSET OF GLIOBLASTOMA

Abstract Glioblastoma (GBM) therapy could strongly profit from simplified procedures for personalized medicine. Cannabidiol (CBD) is explored for GBM-patients, but the mode of drug-action is largely unknown and stratification markers are missing. We investigated CBD-induced cytotoxicity in a panel o...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Neuro-oncology (Charlottesville, Va.) Va.), 2019-11, Vol.21 (Supplement_6), p.vi70-vi71
Hauptverfasser:	Volmar, Marie, Nagl, Bernhard, Haug, Alisha, Richter, Sven, Alenezi, Haithanm, Herold-Mende, Christel, Lamszus, Katrin, Synowitz, Michael, Schick, Joel, Kälin, Roland, Glass, Rainer
Format:	Artikel
Sprache:	eng
Schlagworte:	Drug Discovery
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!